[Corrigendum] miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1

Following the publication of this article, the authors have subsequently realized that Fig. 2D (lower middle panel, K562‑control group treated with paclitaxel) contained the same data as the left lower panel (K562 group). The authors have examined their original data, and realize that the same data was inadvertently included in this Figure twice. Consequently, the corrected version of Fig. 2, featuring the correct data for the lower middle panel (K562‑control group treated with paclitaxel), is shown opposite. The overall conclusions of this study were not affected by this error. The authors regret that this error was introduced into the printed version of the paper, and apologize to the readership for any inconvenience caused. [the original article was published in Oncology Reports 37: 2193‑2200, 2017; DOI: 10.3892/or.2017.5464.